Michael Mints

Michael Mints is an Affiliated to Research and Docent in the Department of Oncology-Pathology at Karolinska Institutet, Stockholm. As a core member of the Schlisio Lab, he investigates oxygen sensing pathways, cancer biology, and intratumor heterogeneity using advanced genomic techniques.

His academic credentials include:

• Docent in Experimental Oncology, Karolinska Institutet (2025)
• PhD in Oncology-Pathology, Karolinska Institutet (2015)
• Medical Degree, Karolinska Institutet (2013)

Dr. Mints' research spans cancer genomics, bioinformatics, and tumor immunology with focus on head and neck squamous cell carcinoma, HPV-related cancers, and bladder cancer. He pioneers single-cell and spatial transcriptomic approaches to dissect tumor microenvironments and immune interactions, revealing critical insights into intratumor heterogeneity and therapeutic resistance mechanisms.

His recent publications (2025-2020) demonstrate consistent output in high-impact journals, with increasing emphasis on multi-omic integration and clinical translation. Key trends include HPV stratification in head and neck cancer, exosome-based biomarker discovery in urology, and oxygen-sensing pathways in tumor development.

As a Docent, Dr. Mints supervises doctoral students and contributes to Karolinska's educational mission. His research is supported by active grants evidenced by continuous high-impact publications and international collaborations across oncology, immunology, and computational biology domains.

He leads projects within the Schlisio Lab focusing on tumor heterogeneity, with strong connections to clinical oncology through Karolinska University Hospital. Current work involves translating single-cell findings into precision medicine applications for head and neck cancer patients.